James Garner
Chief Executive Officer bij PERCHERON THERAPEUTICS LIMITED
Vermogen: 88 631 $ op 31-03-2024
Profiel
James Stuart Garner is currently the Chief Executive Officer, MD & Director at Percheron Therapeutics Ltd.
He is also a Member at the Australian Institute of Co. Directors.
Previously, he served as the Chief Executive Officer, MD & Executive Director at Kazia Therapeutics Ltd.
from 2016 to 2023.
He was also the Vice President-Clinical & Medical Affairs at TBG Diagnostics Ltd.
Additionally, he held the position of Vice President-Research & Development at Takeda Pharmaceuticals Australia Pty Ltd.
from 2009 to 2013.
Dr. Garner obtained a graduate degree and an MBA from The University of Queensland.
He also completed his undergraduate studies at University College London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-08-2023 | 900 000 ( 0.10% ) | 48 735 $ | 31-03-2024 | |
KAZIA THERAPEUTICS LTD
0.33% | 01-05-2023 | 781 819 ( 0.33% ) | 39 896 $ | 30-11-2023 |
Actieve functies van James Garner
| Bedrijven | Functie | Begin |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Chief Executive Officer | 07-08-2023 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Eerdere bekende functies van James Garner
| Bedrijven | Functie | Einde |
|---|---|---|
| KAZIA THERAPEUTICS LIMITED | Chief Executive Officer | 01-05-2023 |
| Takeda Pharmaceuticals Australia Pty Ltd. | Chief Tech/Sci/R&D Officer | 01-01-2013 |
| TBG DIAGNOSTICS LIMITED | Chief Tech/Sci/R&D Officer | 12-11-2008 |
Opleiding van James Garner
| The University of Queensland | Graduate Degree |
| University College London | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KAZIA THERAPEUTICS LIMITED | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
TBG Diagnostics Ltd.
 TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| Takeda Pharmaceuticals Australia Pty Ltd. |
